Clinical trial NCT00182585: Computer-Assisted HIV Prevention for Young Drug Users
Official title: Computer-Assisted HIV Prevention for Young Drug Users
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: HIV
Keywords: HIV
hepatitis
STDs
adolescents
addiction
treatment
prevention
HIV and related risk behavior among youth in drug treatment
Lead sponsor: National Development and Research Institutes, Inc.
Sponsor class: OTHER
Collaborators: name: Daytop (adolescent treament program)
name: St. Luke's-Roosevelt Hospital Center
First posted: 2005-09-16
Enrollment: 56
Sex: ALL
Minimum age (years): 13
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: In this study, the investigators are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies.

Detailed description: Adolescents and young adults who use drugs are at high risk for infection with HIV, STDs and other diseases with similar transmission dynamics. Although several age-appropriate and effective HIV, STD and disease prevention efforts have been identified for young substance abusers, most interventions have been narrow in focus and are generally not structured to readily address changing patterns of drug use among adolescents that place them at risk for infection with these diseases. In this study, we are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies. We plan to develop this program with the input from the target population of adolescents and young adults. We also plan to conduct a randomized, controlled trial to evaluate the benefit of including this program in HIV and disease prevention efforts with youth in substance abuse treatment. In so doing, we will evaluate the ability of the program to promote accurate knowledge about HIV and other diseases, promote self-efficacy to reduce risk behavior and change actual rates of risk behavior among young substance abusers. This computer-based program will be designed to promote the increased adoption of effective HIV and disease prevention science for this population. New information about changing patterns of drug use and HIV risk behaviors can be readily incorporated into the program as it becomes available. The program can be easily exported and able to be applied with fidelity. Importantly, the program will be structured such that a therapist or educator may customize the program content for use by various sub-populations of substance-abusing adolescents and young adults. Thus, the program will be able to address risk factors specific to each young drug user. This program may address many of the challenges associated with the current delivery of evidence-based HIV prevention programs to this population.

Eligibility criteria: Inclusion Criteria:

* Aadolescents in outpatients substance abuse treatment
* Ages 13 - 18 years
* Within first month of treatment entry

Exclusion Criteria:

Primary outcomes:
measure: HIV risk behavior
Secondary outcomes:
measure: knowledge related to HIV, Hepatitis, STDs
measure: behavioral intentions
measure: attitudes toward risk-reduction behavior
measure: feedback on intervention
Other outcomes:
Locations:
city: Brooklyn
country: United States
facility: Daytop
state: New York
city: New York
country: United States
facility: St. Luke's-Hospital, CAPA Program
state: New York
Study officials:
affiliation: National Development and Research Institutes, Inc.
name: Lisa Marsch, PhD
role: PRINCIPAL_INVESTIGATOR
References: